Glaucoma Research Foundation: Advancing Vision & Hope
Glaucoma Articles
This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.
President’s Report from ARVO 2018
ARVO is the annual meeting of the Association for Research in Vision and Ophthalmology.
Niki’s Story: Putting a Positive Spin on her Glaucoma
“Whatever curves life throws at us, I believe one must always make the best out of a situation; there is always a positive side.”
– Niki De Lara
New Drug Rhopressa Now Available for Open-Angle Glaucoma
Rhopressa 0.02% is a novel once-daily eye drop for lowering elevated intraocular pressure.
Generic Medications: Are They the Same?
Generic drugs work well for most patients, but there are differences compared to the brand name products.
Glaucoma and Driving Ability
Concerns about driving often come up with glaucoma and may be brought to the doctor’s attention by the patient or a family member.
Tips on Transferring Your Eye Care to a New Doctor
What will your new doctor need to know to take over management and treatment of your glaucoma?
Genetic Testing in Glaucoma
Glaucoma is a complex disease resulting from a mix of genetic and environmental factors. Family history is an important risk factor for glaucoma.
Can I Have Laser Vision Correction?
Laser refractive surgery is not prohibited for glaucoma suspects or glaucoma patients. With multiple choices now available for refractive correction, both patients and physicians have more options.
Dr. James Brandt on New Horizons in Glaucoma Drug Delivery
James D. Brandt, MD co-moderated the session “New Horizons in Glaucoma Drug Delivery” with Anne L. Coleman, MD, PhD at the 7th annual Glaucoma 360 New Horizons Forum in San Francisco.
Catalyst for a Cure 2018 Research Progress Report
Biomarkers can provide physicians with better tools to diagnose and manage glaucoma before vision is lost, as well as accelerate better treatments for glaucoma.
Dr. Janey Wiggs: Update on Genetic Research for Glaucoma
We talked with Dr. Janey Wiggs, a scientific advisor for Glaucoma Research Foundation, at the AAO 2017 meeting in New Orleans about what’s new in genetic research for treating glaucoma.
Eye Anatomy
To understand glaucoma, it is important to have an idea of how the eye works and the different parts of the eye.
Glaucoma Worldwide: A Growing Concern
The worldwide prevalence of glaucoma is increasing. This is due in part to the rapidly aging population.
Cataracts and Glaucoma
Both cataracts and glaucoma can be a natural part of the aging process. Many people over 60 may have both.
How to Know If You’re at Risk for Glaucoma
One way to help prevent vision loss from glaucoma is to make sure you get regular eye examinations. Early diagnosis and treatment is critical to preserving sight.
What Does Braille Have to Do With Glaucoma?
“My advice for the blind community is to be prepared for what life may throw at you and be open to learn new things.” — Jasmyn Polite
Living with Glaucoma: Tonian McDonald’s Personal Story
Tonian strives to be a face for change and spread awareness of glaucoma in her country of Jamaica, and around the world.
New Medical Therapies Offer Hope for Glaucoma Patients
“It’s always exciting to have new and effective treatment alternatives available to help patients,” said Andrew Iwach, MD.
African Americans and Glaucoma
After cataracts, glaucoma is the leading cause of blindness in African Americans. Half of those with glaucoma don’t know they have it.
2018 Glaucoma Research Update: Dr. Andrew Huberman’s Laboratory
Andrew Huberman, PhD is a principal investigator in the Catalyst for a Cure Biomarkers Team funded by Glaucoma Research Foundation in San Francisco, CA.
2018 Glaucoma Research Update: Vivek Srinivasan’s Laboratory
The Srinivasan Laboratory at the University of California, Davis, develops novel optical imaging techniques and diagnostics with applications spanning from basic to clinical research.
2018 Glaucoma Research Update: Dr. Jeffrey Goldberg’s Laboratory at Stanford
Dr. Goldberg’s glaucoma research is directed at neuroprotection and regeneration of retinal ganglion cells and other retinal neurons.
New Dual Action Glaucoma Medication Promising for Glaucoma Patients
In November 2017, the FDA approved Vyzulta, latanoprostene bunod (LBN), as a potential game-changer in the treatment of glaucoma.
Why Retinal Ganglion Cells Are Important in Glaucoma
Retinal ganglion cells (RGCs) are particularly important in glaucoma because they are the cells that are damaged by the disease.
Help for Glaucoma Patients Who Lose Vision
You and your eye doctor share the same goal in the treatment of glaucoma: to preserve as much of your vision as possible, even if the disease progresses over time.